We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to support the latter’s research and anti-fungal drug development.